Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are:
- To estimate the incidence rate of unexpected adverse events
- To characterize the bleeding events and assess risk factors of bleeding
- To identify ancillary baseline variables that may also be associated with adverse
outcomes